Abstract The roles of interferon regulatory element (IRE) in Hepatitis B virus (HBV) genome on inhibitory effect of interferon against HBV are controversial in vitro. This study aimed to determine the functional characterization of HBV-IRE sequence in vivo. Wild-type or IRE-mutant HBV replication-competent mice were firstly established, and mice were subquently treated with polyinosinic-polytidylin acid (polyI.C) or phosphate-buffered saline via intraperitoneal. Results showed that PolyI.C inhibited viral replication, and increased the level of 2 0 ,5 0 -oligoadenylate synthase mRNA transcripts, a marker of INF-a/b induction. Between wildtype and IRE-mutant HBV replication-competent mice, the levels of HBV-RNA and HBV-DNA replication intermediates were similar. After PolyI.C treatment, the decreasing of HBV-RNA was similar between two groups, but HBV-DNA replication intermediates decreased significantly less in IREmutant than wild-type HBV replication-competent mice. These findings suggested that IRE mutant reduced the inhibitory effect of interferon on HBV replication, which played a role in antiviral effect of interferon against HBV.
Introduction
Hepatitis B virus (HBV) infection is a worldwide health problem [17, 19] . Although a highly effective preventive vaccine is available [5] , it does not help the estimated 350 million people who have already been infected chronically and are at higher risk of developing hepatic cirrhosis and hepatocellular carcinoma, the predominant causes of mortality due to HBV infection [3] . In recent years, several antiviral drugs have been developed for the treatment of chronic hepatitis B patients. Interferon, one of the approved antiviral agents against chronic HBV infection, can suppress HBV replication and improve the clinic outcome in patients with chronic HBV infection [8, 16, 33] . However, the detailed mechanisms responsible for these actions are not clearly understood.
HBV belongs to the family of hepadnaviruses, a group of small enveloped viruses with liver tropism. The HBV genome is a relaxed, circular, partially double-stranded 3.2-kb DNA molecule. HBV replicate by reverse transcription mechanism. The DNA genome of the virus is transcribed in the nucleus of the hepatocyte to generate the 3.5, 2.4, 2.1 and 0.7 kb HBV RNA which encode the HBV core(HBcAg and HBeAg) and polymerase polypeptide, the large surface antigen polypeptide, the middle and major surface antigen polypeptides(HBsAg), and the HBx polypeptide. The expression levels of those transcripts are regulated by the enhancer II/core promoter, the large surface antigen promoter, the major surface antigen promoter and the enhancer I/X gene promoter, respectively. In addition to encoding the core polypeptide and the HBV DNA polymerase, the greaterthan-genome 3.5-kb pregenomic RNA serves as the reverse transcription template to synthesize HBV DNA. Consequently, pregenomic 3.5-kb RNA is the precursor of viral DNA synthesis, and regulation of its transcription can influence directly HBV replication and synthesis of the virus.
Interferon binds to its receptor and activates the latent signal transducer and activator of transcription 1 and 2(STAT1 and STAT2) and interferon regulatory factor(IRF)9/(ISGF3c), which form a heterotrimetric complex, the interferon-stimulated gene factor 3(ISGF3). ISGF3 translocates into the nucleus where it binds to interferonstimulated response element (ISRE) sequence in the promoter or enhancer of a variety of interferon-stimulated genes (ISG) and activates their expression. Interferon regulatory factors (IRFs) are some of target genes of ISGs. After being activating, IRFs could bind to interferon regulatory element (IRE) and regulate its function [15, 35, 36] . Therefore, INFa/b can activate transcription of genes possessing ISRE/IRE sequence in their promoters or enhancers [6, 18, 27] . Previous analysis suggested that an ISRE/IRE sequence was present in the enhancer 1/X gene promoter region of HBV genomic DNA [9, 25] . The presence of HBV-IRE suggested that interferon might directly regulate HBV transcription and, consequently, HBV replication [24] . Studies using reporter gene constructs have demonstrated that the HBV-IRE in enhancer1/X gene promoter was a functional regulatory site capable of mediating regulatory effect of IFNa, ISGF3, IRF1 and IRF7 on gene expression [1] . However, the roles of this HBV-IRE sequence in the inhibitory effect of interferon on HBV are somewhat controversial [26] . Therefore, it is necessary to further define the role of HBV-IRE in antiviral effect of interferon on HBV.
It has been previously demonstrated that the inhibitory effect of interferon on HBV replication in vitro HBV replication system is not obvious [1, 28] , and therefore, most studies about the mechanism by which interferon regulate HBV replication have been performed in vivo by using HBV transgenic mice at present.However, the acquisition of transgenic mice is very time-consuming and laborious. We and others have reported previously that a mouse model with HBV replication was developed by using hydrodynamic-based procedure [21, 34] and this model was rapid, convenient and economical, in particular, allow the application of mutagenesis to the functional study of the HBV genomic region.
Based on these facts, we attempted in the current study to define the role of the HBV-IRE sequence in antiviral effect of interferon against HBV in vivo using the hydrodynamic-based mouse model and the IRE-mutated HBV DNA construct.
Materials and Methods

Plasmids
Plasmid pHBV4.1 containing 1.3 copies of HBV genome has been described previously [21, 30] . The plasmid HBV4.1-IREmut was derived by introducing clustered point mutations into the IRE of the enhancer 1/X gene promoter in the pHBV4.1. The mutation converted the 10 nt IRE sequence located between nucleotide coordinates 1,091 to 1,100 from GAAAGTGAAA to GAAGGTAAAG, but did not alter the HBV polypeptide sequence [1] . The plasmids were prepared by using a plasmid purifying Kit (QIAGEN TIP-500) according to the manufacturer's instructions.
Injection of Naked Plasmid DNA and Treatment of PolyIC Male BALB/C mice at SPF, weighing 18-20 g, were provided by the Huaxi Laboratory Animal Center of Sichuan University. Mice were injected via tail vein with 10 lg of pHBV4.1 or pHBV4.1-IREmut in 2.0 ml of saline within 5-8 s (hydrodynamics-based in vivo transfection) [20] .
Polyinosinic acid-polycytidylic acid (polyIC), as a s synthetic analog of double-stranded RNA, was originally synthesized as a potent inducer of type I IFN. For polyIC treatment, at twenty-four hours after transfection, the wildtype or IRE-mutated HBV replication-competent mice were matched by body weight and serum HBeAg and treated as following: Both the wild type and the IRE mutant HBV replication-competent mice were matched and devided into two groups and treated with polyinosinic-polytidylin acid (polyI.C) (sigma, P-0913) or phosphatebuffered saline (PBS), respectively. PolyIC was injected intraperitoneally at a dose of 200 lg in 200 ll PBS for three times at intervals of twenty-four hours, and PBS was injected as control. The mice were sacrificed 4 to 6 h after the final injection. The serum was stored at -20°C. Their liver tissue was frozen in liquid nitrogen and stored at -70°C prior to analysis for HBVDNA replication intermediates and RNA.
Analysis of HBV RNA and HBV DNA Replication Intermediates
Frozen liver tissue was mechanically pulverized in liquid nitrogen and used for preparation of toltal cellular RNA and HBV DNA replication intermediates. Total RNA were isolated by using TRIZOL reagent according to the manufacturer's instructions. HBV DNA replication intermediates were prepared as previously described [21] . One hundred and twenty microgram of liver tissue powder was lysed in 0.6 ml of 100 mM Tris hydrochloride(PH 8.0) and 0.2 % (vol/vol) NP40. The lysate was centrifuged for 1 min at 1,4000 rpm in a microcentrifuge. The supernatant was adjusted to 6.75 mM magnesium acetate plus 200 lg of DNaseI/ml and incubated for 1 h at 37°C. The superantant was readjusted to10 mM EDTA, 0.8 % (wt/vol) sodium lauryl sulfate, 100 Mm NaCl and 1.6 mg of pronase/ml; it was incubated for additional 1 h at at 37°C. The supernatant was extracted twice with phenol/chloroform, precipitated with 0.7 volume of isopropanol and resuspended in 30ul of 10 mM Tris hydrochloride (PH 8.0) and 1 mM EDTA.
RNA (Northern) and DNA (Southern) filter hybridization analysis was performed with 30ug of total RNA and 30 ll of viral replication intermediates as described previously [31] with some modification. Filters were probed with digoxigenin-labled full-length HBVDNA to detect HBV sequence, and for RNA analysis, the mouse glyceraldehydes 3-phosphate dehydrogenase (GAPDH) cDNA was used as an internal control. Filter hybridization were detected by using DIG Luminesent Detection Kit (Roche Applied Science) and X ray. The relative abundances of specific RNA and DNA molecules were quantitated with Quantity One system.
Serological Analysis for HBeAg
Hepatitis B virus e-antigen (HBeAg) analysis was performed with 50 ll of mouse serum by using enzyme-linked immunosobent assay (ELISA). The HBeAg Detection Kit (Shanghai Shiye Kehua company, China) was used.
RT-PCR Analysis for 2OAS mRNA in Mouse Liver
Intrahepatic mouse 2 0 ,5 0 -oligoadenylate synthase(2OAS) mRNA transcripts were analyzed by RT-PCR. Isolated total RNA from livers of mice received polyIC or PBS treatment was used as a template for reverse transcriptase (TAKARA, China) first-strand reaction with an Oligo dT primer. Multiplx PCR was performed with 2 primer pairs. (1) b-actinspecific primers (sense: CGTTGACATCCGTAAAGACC; anti-sense:AACAGTCCGCCTAGAAGCAC; (2) mouse OAS-specific primers as reviously CAACAATGGCGC ACGGACTCAGGAG; anti-sense:AAAGAGCTC TTA-CAGCA GGATACATGTCC). Reaction products were analyzed by gel electrophoresis on a 1 % agarose gel. The expected bands were 281 bp for b-actin and 1,100 bp for 2OAS. The relative abundances of 2OAS mRNA were quantitated with Quantity One system.
Statistical Analysis
Data were analyzed using the SPSS version 13.0 software package (SPSS, Inc., Chicago, IL, USA). The difference between groups of quantitative data was analyzed by t test; and test of significance was two-tailed, with significance being indicated by a P value \0.05.
Results
Effect of PolyIC Injection on HBV Transcription and Replication in HBV-Transfected Mice
To investigate whether the effect of interferon on HBV transcription and replication could be achieved in the HBV transfected mouse model, we initially investigated the effect of polyIC injection on the level of viral transcripts and replication intermediates in mice transfected with wildtype HBV DNA construct (Fig. 1) . Multiple rather than single polyIC injections were employed in an attempt to sustain the alpha/beta interferon induction and to confirm the effect of interferon on HBV transcription. As shown in Fig. 1a , compared with the control mice that received PBS injection, the levels of the 3.5-, 2.4-and 2.1-kb transcripts in the livers of the mice that received polyIC treatment slightly decreased. The 3.5-kb HBV RNA was reduced by less than one fold based on this RNA filter hybridization analysis (Fig. 1d) . The effect of multiple polyIC injections on HBV transcript in these mice supports the suggestion that induction of alpha/beta interferon does decrease viral RNA levels, although less than previously reported.
As shown in Fig. 1b , the levels of the HBV replication intermediates in mice received polyIC treatment were lower than that in the control mice received PBS treatment. Furthermore, the most significant reduction involved the more mature, high-molecular-weight DNA forms-relaxed circular DNA(RC DNA), which were almost undetectable in most polyIC-treated mice, while single-stranded DNA remained detectable, but at levels lower than those detected in control mice. Quantitative analysis showed that the injection of polyIC, by induction of interferon reduced the level of cytoplasmic HBV replication intermediates appropriately two fold in the mice transfected with wild HBV genome (Fig. 1e) .
The expression 2OAS mRNA, a known marker of INFa/b induction,was also detected by RT-PCR (Fig. 1c) . It was observed that 2OAS mRNA was detectable in all HBV transfected-mice received PBS or polyIC injection, but the polyIC injection increased the level of the 2OAS gene expression to 1.8-fold (Fig. 1f) . This indicated that injection of polyIC did induce the interferon response pathway, and its effects on HBV transcription and replication may be associated with interferon.
Effect of HBV IRE Mutation on Viral Transcription and Replication
To investigate whether the mutation of the enhancer1/X promoter IRE sequence in HBV genome will influence viral transcription and replication in vivo or not, we compared the levels of HBV transcription and replication from the mice with the wild or IRE mutant HBV DNA. The results of three indepent experiments showed that the levels of the HBV 3.5-and 2.4-/2.1-kb mRNA derived from mice injected with wild or IRE mutant HBV DNA were not obviously different (Fig. 2a, c, P [ 0.05) . The levels of HBVDNA replication intermediates were also similar between the two groups of mice (Fig. 2b, d , P [ 0.05). This suggested that mutations introduced in the HBV IRE region in this study did not greatly influence the transcription and replication of HBV in vivo in the HBV replication mouse model.
Influence of HBV IRE Mutation on the Inhibition Effect of Interferon on HBV Replication In Vivo
Having confirmed that effect of interferon on HBV transcription and replication can be achieved and HBV IRE mutation does not influence HBV transcription and replication in the HBV replication mouse model in vivo, we used this model to investigate the role of HBV IRE in the antiviral effect induced by interferon. The difference between the modulation effect on transcription and replication from wildtype HBV and that from IRE-mutated HBV induced by polyIC was compared (Fig. 3) . It was observed that the levels of the HBV 3.5-and 2.4/2.1-kb transcripts in the the livers of the HBV transfected mice with wild and IRE-mutated HBV DNA were both reduced by the induction of interferon response with polyIC injection (Fig. 3a, c) . Quantitative analysis showed that interferon decreased the wild and mutant HBV transcripts to similar extent, and 3.5-kb HBV RNA were reduced similarly (Fig. 3c) . These results suggested that the inhibitory effect of interferon on HBV transcription was not greatly influenced by IRE mutation.
In contrast to the similar effects on HBV transcription, interferon reduced HBV replication intermediates from the d Quantitative analysis of the 3.5 kb HBV RNA. e Quantitative analysis of HBV DNA replication intermediates. The levels of 3.5 kb HBV RNA and HBV DNA intermediates (HBV DNA RI) are reported to the levels of the mice treated with PBS, which are set at 1.0. f Quantitative analysis of the OAS RNA. The RNA levels of OAS are reported to the levels of the mice treated with PBS, which are set at 1.0. The symbol ''asterisk'' represents the probability of a significant difference between the two groups wild and IRE mutant viral genome to different extent. The level of cytoplasmic HBV replication intermediates was reduced by appropriately twofold in the mice with wild type HBV DNA after polyIC injection (Fig. 3b, d ). However, polyIC injection reduced HBV replication intermediates form the IRE mutant HBV DNA only onefold, to a somewhat lesser extent. And the difference in relative decreasing level of HBV replication intermediates induced by polyIC between two groups was statistic significantly (P \ 0.05). This indicated that mutation of HBV IRE reduced the inhibitory effect of interferon on HBV replication.
Discussion
Antiviral therapy is critical for treatment of patients with chronic HBV infection, and treatment with interferon is one of standard antiviral therapy at present [13] . Although the treatment with interferon can reduce virus load and ameliorate disease symptoms of chronically infected HBV patients, an effective reduction in virus load is only observed in less than half of the treated patients. The mechanism by which interferon inhibits HBV and the reasons that the patient did not response to interferon treatment remain unclear.
In this study, the role of HBV IRE in antiviral effect of interferon was investigated. It was observed that mutation of the enhancer1/X gene promoter IRE sequence in HBV genome partly reduced the inhibitory effect of interferon induced by polyIC on HBV replication. In addition, a clinical study in our department was performed to investigate the relationship between HBV IRE sequence mutation and antiviral effect of interferon in interferon treated patients. The results of that study suggested that, in some patients, the poor virological response to the interferon treatment is probably associated with a mutation in the HBV IRE region (unpublished data). Therefore, it is appears that interferon inhibits viral replication from wildtype HBV genome partly through an IRE-dependent mechanism and mutation of HBV IRE might be one of the reasons that HBV does not respond to interferon treatment. These information may throw some light on clinical application, for example, antiviral effect of interferon may be predicted based on HBV IRE sequencing, and also, new antiviral agents targeting to this gene region can be designed in an attempt to improve antiviral effect. 2OAS, one of upregulated genes by interferon, is usually known as a marker of induction of interferon response [7, 32, 37] . In our current study, it was observed that the level of the 2OAS gene expression in polyIC-treated mice is higher than that of control mice treated with PBS. Furthermore, the levels of the HBV replication intermediates in mice received polyIC treatment were lower than that in the control mice received PBS treatment, and also, the levels of HBV RNA of the mice that received polyIC treatment decreased, although slightly. The observations suggest that polyIC induced interferon response in HBVtransfected mice, and interferon suppressed the replication of HBV. In addition, it was shown that polyIC injection inhibited viral replication from wild-type viral genome to a much greater degree than IRE-mutated HBV DNA. Therefore, all these results indicated that mutation of HBV IRE reduced the inhibitory effect of interferon on HBV replication, and the IRE play a role in inhibition effect of interferon on HBV.
In this analysis, it was shown that the induction of interferon by polyIC also inhibited viral replication from IRE-mutated HBV DNA construct, although to a somewhat lesser extent than wild-type viral genome. This suggests that mutation of the IRE sequence in the HBV Ehn1/Xp region did only partially reduce but not completely block the interferon-mediated suppressive effect on viral replication, which might be due to the fact that interferon inhibits HBV replication by more than one single mechanism. Firstly, interferon regulates HBV DNA replication by both immunomodulatory [4] and directly antiviral mechamism. Furthermore, as far as direct antiviral mechamism is concerned, except for HBV IRE-dependant pathway, interferon has the potential to trigger the activation of other multiple noncytolytic intracellur antiviral pathways that can target many steps in the viral life [2, 11, 12, 23] . In a word, multiple mechanisms might be involved in antiviral effect by interferon on HBV, and IRE-dependant mechanism investigated in our present study was one of them. Moreover, interferon regulates the function of IRE through activating a series of cytokines, so the level of these cytokines may influence its antiviral effect. These may explane the results that mutation of IRE sequence could only partly reduce the regulatory effect induced by interferon on HBV replication.
In this study, it was also observed that polyIC treatment reduced the level of cytoplasmic HBV replication intermediates to a greater extent than that of HBV RNA in the mice transfected with whether wild-type or IRE-mutated HBV genome. Additionally, mutation of HBV IRE reduced interferon-mediated inhibition of viral replication without obvious influence on transcription. These observations indicate that subtle alterations in viral transcription may be associated with major alterations in levels of replication intermediates as observed in HBV transgenic mice. Evidence showed that a small variation of RNA transcription could probably lead to great changes of DNA levels. For example, analysis of the role of HNF1a in modulating HBV replication in vivo indicated that the steady levels of HBV transcripts were not influenced by this transcription factor, but the levels of replication intermediates in the livers of the HNF1a-null HBV transgenic mice were approximately two-and four-fold higher in male and female mice, respectively, compared with that observed in the HBV transgenic mice expressing functional HNF1a. Similarly, peroxisome proliferators were shown to increase HBV replication in a PPARa-dependent manner without significantly affecting the levels of the HBV transcripts. In addition, various stimuli including polyIC treatment result in dramtically reduced viral replication without readily detectable alteration in viral transcription [10] . Therefore, similarly to HBV transgenic mice, in HBV transfected mice viral replication can be regulated by activity of transcription factors without measurably affecting viral transcription. Finally, we found that in our current study, the gene expression of 2OAS was detectable in all HBV transfected mice received PBS or polyIC treatment. This result indicates that transfection of viral DNA may induce interferon response. This is probably because that viral DNA introduced and nuclei and protein molecules produced in vivo triggered antiviral response, which was supported by previous observations [14, 22, 29, 34] . It had been previously observed that HBV transfected mouse established with immuo-competent mouse is a short-term HBV replication model, with viral gene expression lasting for only about 10-15 days. Furthermore, the disappearance of HBV antigens, viral transcripts and replication intermediates from the blood and liver coincided with the appearance of antiviral antibodies and evolution of the CTL response to HBV. In contrast, the virus persisted for at least 81 days after transfection of immunocomprised mice. All these observations indicated that transfection of HBV DNA triggered immune system to induce antiviral state. Because interferons stand in the frontline of defense against viral infection, it is not surprising that transfection of the viral genome induces interferon response.
It has been demonstrated that the levels of HBV replication presumably differ from mouse to mouse even in the same experiment conditions. Additionally, there were some variations in the response to interferon between different mice, as antiviral effect of interferon is relevant to host as well as virus factor, which is demonstrated in its clinical use for treatment of patients with chronic HBV infection. Therefore, in our study mice were matched by body weight and serum HBeAg before being treated with polyIC, more than three mice were used in every experiment and all of these experiments were repeated for at least three times to ensure accuracy and reliability of the experiment results.
In conclusion, the function of IRE was investigated in vivo by using HBV replication-competent mouse model, and it was demonstrated that mutation of IRE sequence in the enhancer1/X gene promoter partly decreased the inhibitory effect of interferon on HBV replication, suggesting that interferon inhibits HBV replication partly by an IRE-dependent mechanism, means that HBV IRE plays a role in the antiviral effect on HBV induced by interferon.
